Arrowstreet Capital, Limited Partnership Novartis Ag Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Novartis Ag stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 11,052 shares of NVS stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,052
Previous 899,920
98.77%
Holding current value
$1.21 Million
Previous $104 Million
98.96%
% of portfolio
0.0%
Previous 0.09%
Shares
29 transactions
Others Institutions Holding NVS
# of Institutions
1,474Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.21 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$895 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$751 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$610 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...